NextCure Inc
PublicNextCure Inc is now publicly traded
The data on this page reflects NextCure Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series A
Mar 5, 2026
Total Funding Raised
$19M
Company Overview
NextCure Inc is a biotechnology company that discovers and develops novel immunomedicines to treat cancer and other immune-related diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
antibody-drug conjugatesADCsimmuno-oncologyclinical-stage biopharmadrug discovery platformtreatment resistant cancernovel target identificationsolid tumorsmonoclonal antibodybiopharma partnershipstumor microenvironmentfusion proteinAcute Myeloid LeukemiaAML
NextCure Inc Comparables
Compare NextCure Inc with similar companies based on industry and business-model similarity.
NextCure Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2026 |
NextCure Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Oncology Ventures | Series A |
| Cencora Ventures | Series A |
NextCure Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersUnited States
Employee Range49
Year Founded2015
Last FundingMar 5, 2026